Stockreport

Adagene Reports Full Year 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]

Adagene Inc. - ADS, each representing 1.25 ordinary shares  (ADAG) 
PDF microsatellite-stable (MSS) colorectal cancer (CRC) with higher, more frequent and repeat dosing of anti-CTLA-4 therapy in combination with anti-PD-1 - - Ongoing combi [Read more]